SB175 (2020) Detail

Relative to qualifying medical conditions for therapeutic cannabis.


SB 175  - AS INTRODUCED

 

 

2019 SESSION

19-0182

01/04

 

SENATE BILL 175

 

AN ACT relative to qualifying medical conditions for therapeutic cannabis.

 

SPONSORS: Sen. Reagan, Dist 17; Rep. Roy, Rock. 32

 

COMMITTEE: Health and Human Services

 

─────────────────────────────────────────────────────────────────

 

ANALYSIS

 

This bill changes the definition of qualifying medical condition for the purposes of the law governing the use of cannabis for therapeutic purposes.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

19-0182

01/04

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Nineteen

 

AN ACT relative to qualifying medical conditions for therapeutic cannabis.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Use of Cannabis for Therapeutic Purposes; Definitions; Qualifying Medical Conditions.  Amend RSA 126-X:1, IX to read as follows:

IX.[(a)]  "Qualifying medical condition" means [the presence of:

(1)  Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, Ehlers-Danlos syndrome, or one or more injuries or conditions that has resulted in one or more qualifying symptoms under subparagraph (2); and

(2)  A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms; or

(b)  "Qualifying medical condition" also means:

(1)  Moderate to severe chronic pain.

(2)  Severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects.

(3)  Moderate or severe post-traumatic stress disorder] any condition for which treatment is determined to be necessary by a provider.

2  Effective Date.  This act shall take effect 60 days after its passage.

Links

SB175 at GenCourtMobile
SB175 Discussion

Action Dates

Date Body Type
March 12, 2019 Senate Hearing
March 27, 2019 Senate Floor Vote
Senate Floor Vote
Jan. 8, 2020 Senate Floor Vote

Bill Text Revisions

SB175 Revision: 7580 Date: Nov. 15, 2019, 9:48 a.m.

Docket

Date Status
Jan. 3, 2019 Introduced 01/03/2019 and Referred to Health and Human Services; SJ 4
March 12, 2019 Hearing: 03/12/2019, Room 101, LOB, 02:00 pm; SC 13
March 27, 2019 Committee Report: Rereferred to Committee, 03/27/2019; SC 15
March 27, 2019 Special Order to the beginning of the regular calendar, Without Objection, MA; 03/27/2019; SJ 10
March 27, 2019 Rereferred to Committee, MA, VV; 03/27/2019; SJ 10
Committee Report: Inexpedient to Legislate
Jan. 8, 2020 Committee Report: Inexpedient to Legislate, 01/08/2020; SC 47
Jan. 8, 2020 Inexpedient to Legislate, MA, VV === BILL KILLED ===; 01/08/2020; SJ 1